Key result
Female sex is not linked to higher in-hospital mortality or complications after AF ablation.
Why the study?
Prior research showed mixed results regarding in-hospital complications following atrial fibrillation ablation in women compared to men.
Does female sex affect in-hospital mortality and complications following atrial fibrillation ablation compared to male sex?
Observational (n=1,664,715)
Yes
Does female sex affect in-hospital mortality and complications following atrial fibrillation ablation compared to male sex?
Effect estimate: adjusted OR 0.94 (95% CI 0.36-2.49)
Absolute Event Rate: 0.39% vs 0.36%
p-value: p=0.84
While women admitted with atrial fibrillation are less likely to undergo catheter ablation than men, their risk-adjusted in-hospital mortality and complication rates following the procedure are similar.
Supports similar periprocedural outcomes by sex after AF ablation; leaves open factors driving lower utilization in women.
Background Research has shown mixed results when comparing in‐hospital complications following atrial fibrillation ablation in women compared to men. Objectives To better quantify sex differences and in‐hospital outcomes in atrial fibrillation ablation procedures and identify factors associated with poorer outcomes. Methods We queried the NIS database from 2016 to 2019 for hospitalizations with a primary diagnosis of atrial fibrillation ablation and excluded patients with any other arrhythmias, ICD/pacemaker placement. We assessed demographics, in‐hospital mortality, and complications of women compared to men. Results Admissions for atrial fibrillation were more common in females than males (849 050 vs. 815 665; p < .001). However, females were less likely to receive ablation (1.65% vs. 2.71%, OR: 0.60; 95% confidence interval: 0.57–0.64, p < .001), which persisted after adjusting for cardiomyopathy (adjusted OR: 0.61; 95% confidence interval: 0.58–0.65, p < .001). The primary outcome of in‐hospital mortality was not statistically different in univariate analysis (0.39% vs. 0.36%, OR: 1.09, 95% CI: 0.44–2.72, p = .84), finding that did not change when adjusted for comorbidities (adjusted OR: 0.94, 95% CI: 0.36–2.49). The complication rate in hospitalized patients following ablation was 8.08%. The total unadjusted complication rate was higher for females than males (9.58% vs. 7.09%, p = .001); however, it was not significant when adjusted for risks (adjusted OR: 1.23, 95% CI: 0.99–1.53, p = .06). Conclusion Female sex is not associated with increased complications or death in a real‐world study of catheter ablation when results are adjusted for risks. However, females admitted with atrial fibrillation receive ablation less often than males during hospital admission.
No takes yet. Share an insight, caveat, or question.
Shrestha et al. (2023) conducted an observational in Atrial fibrillation (n=1,664,715). Female sex vs. Male sex was evaluated on In-hospital mortality (adjusted OR 0.94, 95% CI 0.36-2.49, p=0.84). Female sex was not associated with increased in-hospital mortality (adjusted OR 0.94; 95% CI 0.36-2.49) or complications following atrial fibrillation ablation compared to males.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: